Gene Mutation Found for Aggressive Form of Pancreatic Cancer
By LabMedica International staff writers Posted on 04 Jun 2014 |
![Image: The RotorGene RG-3000 thermal cycler system (Photo courtesy of Corbett Research). Image: The RotorGene RG-3000 thermal cycler system (Photo courtesy of Corbett Research).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2014-06-04/RLJ-157a.jpg)
Image: The RotorGene RG-3000 thermal cycler system (Photo courtesy of Corbett Research).
![Image: Photomicrograph of pancreatic adenosquamous carcinoma (Photo courtesy of Ralph H Hruban and Noriyoshi Fukushima). Image: Photomicrograph of pancreatic adenosquamous carcinoma (Photo courtesy of Ralph H Hruban and Noriyoshi Fukushima).](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2014-06-04/RLJ-157b.jpg)
Image: Photomicrograph of pancreatic adenosquamous carcinoma (Photo courtesy of Ralph H Hruban and Noriyoshi Fukushima).
A mutated gene common to adenosquamous carcinoma tumors has been discovered and is the first known unique molecular signature for this rare, but particularly virulent, form of pancreatic cancer.
Pancreatic adenosquamous carcinoma (ASC) is an enigmatic and aggressive tumor that has a worse prognosis and higher metastatic potential than its adenocarcinoma counterpart. There has been little progress in understanding pancreatic ASC, as no mutations unique to this class of pancreatic tumors have been identified.
Scientists at the University of California, San Diego School of Medicine (La Jolla, CA, USA) and an international team evaluated a set of tumors and corresponding normal tissues from 23 patients with ASC of the pancreas, as well as tumors from 24 patients with ductal adenocarcinoma, three patients with solid pseudopapillary neoplasm, two patients with neuroendocrine carcinoma and 21 patients with lung squamous cell carcinoma. Of the 23 ASC patient specimens, there were 19 formalin-fixed, paraffin-embedded (FFPE) tissue sections available. The other four ASC patient specimens were frozen immediately after collection.
Genomic DNA from the frozen samples was extracted using the DNeasy Blood & Tissue Kit (Qiagen; Valencia, CA, USA) and genomic DNA from the FFPE samples was extracted using Qiagen’s QIAamp DNA FFPE Tissue Kit. Quantitative real-time reverse-transcription PCR (RT-qPCR) analysis was performed using the relative quantification method in a RotorGene RG-3000 thermal cycler system (Corbett Research; Mortlake, NSW, Australia).
The investigators found that that ASC pancreatic tumors have somatic or non-heritable mutations in the Up-frameshift 1 (UPF1) gene, which is involved in a highly conserved RNA degradation pathway called nonsense-mediated RNA decay or NMD. It is the first known example of genetic alterations in an NMD gene in human tumors. NMD has two major roles. First, it is a quality control mechanism used by cells to eliminate faulty messenger RNA (mRNA). Second, it degrades a specific group of normal mRNAs, including those encoding proteins promoting cell growth, cell migration and cell survival.
Miles F. Wilkinson, PhD, co-senior author, said, “There has been little progress in understanding pancreatic ASC since these aggressive tumors were first described more than a century ago. One problem has been identifying mutations unique to this class of tumors.” The study was published on May 25, 2014, in the journal Nature Medicine.
Related Links:
University of California, San Diego School of Medicine
Qiagen
Corbett Research
Pancreatic adenosquamous carcinoma (ASC) is an enigmatic and aggressive tumor that has a worse prognosis and higher metastatic potential than its adenocarcinoma counterpart. There has been little progress in understanding pancreatic ASC, as no mutations unique to this class of pancreatic tumors have been identified.
Scientists at the University of California, San Diego School of Medicine (La Jolla, CA, USA) and an international team evaluated a set of tumors and corresponding normal tissues from 23 patients with ASC of the pancreas, as well as tumors from 24 patients with ductal adenocarcinoma, three patients with solid pseudopapillary neoplasm, two patients with neuroendocrine carcinoma and 21 patients with lung squamous cell carcinoma. Of the 23 ASC patient specimens, there were 19 formalin-fixed, paraffin-embedded (FFPE) tissue sections available. The other four ASC patient specimens were frozen immediately after collection.
Genomic DNA from the frozen samples was extracted using the DNeasy Blood & Tissue Kit (Qiagen; Valencia, CA, USA) and genomic DNA from the FFPE samples was extracted using Qiagen’s QIAamp DNA FFPE Tissue Kit. Quantitative real-time reverse-transcription PCR (RT-qPCR) analysis was performed using the relative quantification method in a RotorGene RG-3000 thermal cycler system (Corbett Research; Mortlake, NSW, Australia).
The investigators found that that ASC pancreatic tumors have somatic or non-heritable mutations in the Up-frameshift 1 (UPF1) gene, which is involved in a highly conserved RNA degradation pathway called nonsense-mediated RNA decay or NMD. It is the first known example of genetic alterations in an NMD gene in human tumors. NMD has two major roles. First, it is a quality control mechanism used by cells to eliminate faulty messenger RNA (mRNA). Second, it degrades a specific group of normal mRNAs, including those encoding proteins promoting cell growth, cell migration and cell survival.
Miles F. Wilkinson, PhD, co-senior author, said, “There has been little progress in understanding pancreatic ASC since these aggressive tumors were first described more than a century ago. One problem has been identifying mutations unique to this class of tumors.” The study was published on May 25, 2014, in the journal Nature Medicine.
Related Links:
University of California, San Diego School of Medicine
Qiagen
Corbett Research
Latest Molecular Diagnostics News
- New Urine Test Improves Accuracy for Early Detection of Bladder Cancer in Patients with Hematuria
- New Blood Test Enables Accurate Diagnosis of Dementia and Neurological Diseases
- Low-Cost CRISPR-Based Paper Strip Test to Improve Flu Diagnosis and Surveillance
- AI-Powered Blood Test Predicts Parkinson's Seven Years before Symptoms Appear
- Rapid Diagnostic Test for Brain Tumors to Reduce Need for Invasive Surgical Biopsy
- New Blood Test Identifies Children with Rare Heart Condition
- Novel Immune-Based Biomarker Helps Detect Ovarian Cancer Years before Diagnosis
- Advanced Liquid Biopsy Technology Detects Cancer Earlier Than Conventional Methods
- Blood-Based Test Outperforms Ultrasound in Early Liver Cancer Detection
- Four-In-One Molecular Test Detects and Differentiates Among Most Prevalent Respiratory Viruses in 20 Minutes
- First-Line PSA Testing More Cost-Effective Than First-Line MRI for Prostate Cancer Screening
- Proteomics Platform Identifies Proteins in Blood to Give Cancer Warning 7 Years before Diagnosis
- AI Technology-Based Blood Test Identifies Lung Cancer Earlier
- Ultra-Sensitive Blood Test Predicts Breast Cancer Recurrence Months or Even Years before Relapse
- Prenatal Testing Offers Window for Finding Mother’s Cancer Risk
- New Molecular Test Detects More Cervical Cancer Cases
Channels
Clinical Chemistry
view channel![Image: The proposed self-powered, millifluidic lab-on-a-chip device to determine blood conductivity (Photo courtesy of Advanced Materials/DOI: 10.1002/adma.202403568) Image: The proposed self-powered, millifluidic lab-on-a-chip device to determine blood conductivity (Photo courtesy of Advanced Materials/DOI: 10.1002/adma.202403568)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-25/adma202403568-fig-0001-m.jpg)
First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
Metabolic disorders such as diabetes and osteoporosis are rapidly increasing globally, especially in developing countries. Diagnosing these conditions generally requires blood tests; however, in remote... Read more![Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF) Image: The new ADLM guidance will help healthcare professionals navigate respiratory virus testing in a post-COVID world (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-27/98234491_m_normal_none.jpg)
New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
Respiratory tract infections, predominantly caused by viral pathogens, are a common reason for healthcare visits. Accurate and swift diagnosis of these infections is essential for optimal patient management.... Read moreHematology
view channel![Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA) Image: The new Yumizen H550E (autoloader), H500E CT (closed tube), and Yumizen H500E OT (open tube) (Photo courtesy of HORIBA)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-25/csm_Yumizen_H550E-H500E_OT_-H500E_CT__Hematology___ESR_Analyzers_HORIBA_0a23a24ac7.jpg)
New Hematology Analyzers Deliver Combined ESR and CBC/DIFF Results in 60 Seconds
HORIBA (Kyoto, Japan) has expanded its line of compact hematology analyzers by introducing new models that incorporate Erythrocyte Sedimentation Rate (ESR) measurement capabilities. The newly launched... Read more![Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia) Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-09/C3_DBS_Website.2.jpg)
Next Generation Instrument Screens for Hemoglobin Disorders in Newborns
Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more![Image: The Procleix ArboPlex Assay has received the CE mark (Photo courtesy of Grifols) Image: The Procleix ArboPlex Assay has received the CE mark (Photo courtesy of Grifols)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-08/donor-testing-1.jpg)
First 4-in-1 Nucleic Acid Test for Arbovirus Screening to Reduce Risk of Transfusion-Transmitted Infections
Arboviruses represent an emerging global health threat, exacerbated by climate change and increased international travel that is facilitating their spread across new regions. Chikungunya, dengue, West... Read more![Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health) Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-03-20/news-7.jpg)
POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy
Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read moreImmunology
view channel![Image: The finger-based test takes a minute to noninvasively capture enough information to evaluate white cell levels (Photo courtesy of Leuko Labs) Image: The finger-based test takes a minute to noninvasively capture enough information to evaluate white cell levels (Photo courtesy of Leuko Labs)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-21/pointcheck_blur.jpg)
Portable Device Analyzes White Blood Cell Activity to Monitor Cancer Patients’ Health
Chemotherapy and similar treatments aimed at eliminating cancer cells often adversely affect patients' immune cells. Each year, this results in tens of thousands of cancer patients suffering from weakened... Read more![Image: The new test’s measurement is a thousand times more sensitive than current standard test (Photo courtesy of 123RF) Image: The new test’s measurement is a thousand times more sensitive than current standard test (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-19/shutterstock_2342287665.jpg)
New Test Detects Return of Blood Cancer a Year Earlier
Multiple myeloma, also known as Kahler's disease, is a type of blood cancer originating in the bone marrow characterized by the uncontrolled proliferation of plasma cells, a specific type of white blood cell.... Read more![Image: PROMAD is a molecular atlas consisting of more than 12,000 patient samples from around the globe (Photo courtesy of WIMR) Image: PROMAD is a molecular atlas consisting of more than 12,000 patient samples from around the globe (Photo courtesy of WIMR)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-19/463b6897-fa20-4dfd-9638-d1505181496d.jpeg)
Universal Blood Test Could Predict Organ Transplant Outcomes with Unprecedented Accuracy
In a landmark study, an interdisciplinary research team from The Westmead Institute for Medical Research (WIMR, NSW, Australia) and the University of Sydney (NSW, Australia) has identified, for the first... Read moreMicrobiology
view channel![Image: The PA-100 AST System for rapid AMR detection has won the “Longitude Prize on AMR” (Photo courtesy of Sysmex Astrego) Image: The PA-100 AST System for rapid AMR detection has won the “Longitude Prize on AMR” (Photo courtesy of Sysmex Astrego)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-17/PA-100-diskette-device_1.jpg)
Rapid UTI Test Cuts Detection Time from 3 days to 45 Minutes
Antimicrobial Resistance (AMR), also known as antibiotic resistance or superbugs, is a silent but growing pandemic where bacteria have become resistant to lifesaving antibiotics due to decades of overuse and misuse.... Read more![Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical) Image: The POC PCR test shortens time for STI test results (Photo courtesy of Visby Medical)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-05/device-front.jpg)
POC STI Test Shortens Time from ED Arrival to Test Results
In a 2024 sexually transmitted infections (STIs) surveillance report by the World Health Organization (WHO), over 2.5 million cases were recorded, alongside a rise in the inappropriate use of antibiotics... Read more![Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock) Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-08/shutterstock_1065839396.jpg)
Integrated Solution Ushers New Era of Automated Tuberculosis Testing
Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more![Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB) Image: The ASTar System has received US FDA 510(k) clearance (Photo courtesy of Q-linea AB)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-07/ASTar_ft-1-700x494.jpg)
Automated Sepsis Test System Enables Rapid Diagnosis for Patients with Severe Bloodstream Infections
Sepsis affects up to 50 million people globally each year, with bacteraemia, formerly known as blood poisoning, being a major cause. In the United States alone, approximately two million individuals are... Read morePathology
view channel![Image: Green boxes highlight plasma cells — an indicator of infection — in a sample of the tissue lining the uterus (Photo courtesy of Zou lab and Montine lab) Image: Green boxes highlight plasma cells — an indicator of infection — in a sample of the tissue lining the uterus (Photo courtesy of Zou lab and Montine lab)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-26/AI-pathology (1).jpg)
Customizable AI Tool Helps Pathologists Identify Diseased Cells
Pathologists are tasked with examining body fluids or tissues to diagnose diseases, a process that involves distinguishing rare disease-indicating cells from thousands of normal cells under a microscope.... Read more![Image: Cells dying by necroptosis, an inflammatory form of cell death (Photo courtesy of WEHI) Image: Cells dying by necroptosis, an inflammatory form of cell death (Photo courtesy of WEHI)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-25/atlas-3-800-494-800x477.jpg)
New Automated Diagnostic Techniques to Improve Diagnosis of Inflammatory Diseases
Necroptosis, a type of cell death, is a natural mechanism through which the body eliminates unwanted or dangerous cells. This process can malfunction in some individuals, leading to diseases characterized... Read moreTechnology
view channel![Image: Illustration of the microneedle patch (Photo courtesy of Karolinska Institutet) Image: Illustration of the microneedle patch (Photo courtesy of Karolinska Institutet)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-06-05/plaster_custom20240529112158.jpg)
Microneedle Patch Detects Skin Cancer Early
Wearable bioelectronics has emerged as a significant innovation in healthcare, especially in the field of biosensing, providing a new method to monitor individual health for both diagnostic and therapeutic purposes.... Read more![Image: The nanopore optofluidic chip used in the new diagnostic system (Photo courtesy of UC Santa Cruz) Image: The nanopore optofluidic chip used in the new diagnostic system (Photo courtesy of UC Santa Cruz)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-04-09/new-diagnostic-tool-ac.jpg)
New Diagnostic System Achieves PCR Testing Accuracy
While PCR tests are the gold standard of accuracy for virology testing, they come with limitations such as complexity, the need for skilled lab operators, and longer result times. They also require complex... Read moreIndustry
view channel![Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche) Image: For 46 years, Roche and Hitachi have collaborated to deliver innovative diagnostic solutions (Photo courtesy of Roche)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-28/download.jpg)
Roche and Hitachi High-Tech Extend 46-Year Partnership for Breakthroughs in Diagnostic Testing
Roche (Basel, Switzerland) and Hitachi High-Tech (Tokyo, Japan) have renewed their collaboration agreement, committing to a further 10 years of partnership. This extension brings together their long-standing... Read more![Image: Scientists will evaluate new blood-based biomarkers using highly sensitive technology (Photo courtesy of 123RF) Image: Scientists will evaluate new blood-based biomarkers using highly sensitive technology (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-13/103048801_m_normal_none.jpg)
Danaher and Johns Hopkins University Collaborate to Improve Neurological Diagnosis
Unlike severe traumatic brain injury (TBI), mild TBI often does not show clear correlations with abnormalities detected through head computed tomography (CT) scans. Consequently, there is a pressing need... Read more![Image: Beckman Coulter is now an authorized distributor of the MeMed Key immunoassay system and MeMed BV assay (Photo courtesy of Beckman Coulter) Image: Beckman Coulter is now an authorized distributor of the MeMed Key immunoassay system and MeMed BV assay (Photo courtesy of Beckman Coulter)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-09/PR_partnership_with_Beckman_Coulter_v1_2.jpg)
Beckman Coulter and MeMed Expand Host Immune Response Diagnostics Partnership
Beckman Coulter Diagnostics (Brea, CA, USA) and MeMed BV (Haifa, Israel) have expanded their host immune response diagnostics partnership. Beckman Coulter is now an authorized distributor of the MeMed... Read more![Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF) Image: Thermo Fisher will distribute Bio-Techne products across Europe (Photo courtesy of 123RF)](https://globetechcdn.com/mobile_labmedica/images/stories/articles/article_images/2024-05-01/130140677_m_normal_none (1)_1.jpg)